Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


Articles published in Am J Cardiol

Retrieve available abstracts of 41 articles:
HTML format
Text format



Single Articles


    July 2017
  1. SATTAR N, Toth PP, Blom DJ, Koren MJ, et al
    Effect of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Evolocumab on Glycemia, Body Weight, and New-Onset Diabetes Mellitus.
    Am J Cardiol. 2017 Jul 31. pii: S0002-9149(17)31220.
    PubMed     Text format     Abstract available


  2. CAOBELLI F, Haaf P, Chronis J, Haenny G, et al
    Prognostic Usefulness of Cardiac Stress Test Modalities in Patients With Type 2 Diabetes Mellitus Who Underwent Myocardial Perfusion Scintigraphy (from the Basel Asymptomatic High-Risk Diabetics' Outcome Trial).
    Am J Cardiol. 2017 Jul 20. pii: S0002-9149(17)31110.
    PubMed     Text format     Abstract available


  3. ROCHLANI Y, Kattoor AJ, Pothineni NV, Palagiri RDR, et al
    Balancing Primary Prevention and Statin-Induced Diabetes Mellitus Prevention.
    Am J Cardiol. 2017 Jul 14. pii: S0002-9149(17)31116.
    PubMed     Text format     Abstract available


  4. THRASHER J
    Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies.
    Am J Cardiol. 2017;120.
    PubMed     Text format     Abstract available


  5. LEHRKE M, Marx N
    Diabetes Mellitus and Heart Failure.
    Am J Cardiol. 2017;120.
    PubMed     Text format     Abstract available


  6. PANENI F, Luscher TF
    Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes.
    Am J Cardiol. 2017;120.
    PubMed     Text format     Abstract available


  7. WANNER C
    EMPA-REG OUTCOME: The Nephrologist's Point of View.
    Am J Cardiol. 2017;120.
    PubMed     Text format     Abstract available


  8. PHAM SV, Chilton RJ
    EMPA-REG OUTCOME: The Cardiologist's Point of View.
    Am J Cardiol. 2017;120.
    PubMed     Text format     Abstract available


  9. PERREAULT L
    EMPA-REG OUTCOME: The Endocrinologist's Point of View.
    Am J Cardiol. 2017;120.
    PubMed     Text format     Abstract available


  10. STAELS B
    Cardiovascular Protection by Sodium Glucose Cotransporter 2 Inhibitors: Potential Mechanisms.
    Am J Cardiol. 2017;120.
    PubMed     Text format     Abstract available


    June 2017
  11. SHAYA GE, Juraschek SP, Feldman DI, Brawner CA, et al
    Relation of Exercise Capacity to Risk of Development of Diabetes in Patients on Statin Therapy (the Henry Ford Exercise Testing Project).
    Am J Cardiol. 2017 Jun 15. pii: S0002-9149(17)30948.
    PubMed     Text format     Abstract available


    May 2017
  12. KARGOLI F, Shulman E, Aagaard P, Briceno DF, et al
    Socioeconomic Status as a Predictor of Mortality in Patients Admitted With Atrial Fibrillation.
    Am J Cardiol. 2017;119:1378-1381.
    PubMed     Text format     Abstract available


    April 2017
  13. KUMAGAI N, Nusser JA, Inoue H, Okumura K, et al
    Effect of Addition of a Statin to Warfarin on Thromboembolic Events in Japanese Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus.
    Am J Cardiol. 2017 Apr 27. pii: S0002-9149(17)30699.
    PubMed     Text format     Abstract available


  14. CAVUSOGLU E, Kassotis JT, Marmur JD, Banerji MA, et al
    Usefulness of Plasma Tissue Inhibitor of Matrix Metalloproteinase-4 to Predict Death and Myocardial Infarction in Patients With Diabetes Mellitus Referred for Coronary Angiography.
    Am J Cardiol. 2017 Apr 12. pii: S0002-9149(17)30638.
    PubMed     Text format     Abstract available


    March 2017
  15. ERTELT K, Brener SJ, Mehran R, Ben-Yehuda O, et al
    Comparison of Outcomes and Prognosis of Patients With Versus Without Newly Diagnosed Diabetes Mellitus After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (the HORIZONS-AMI Study).
    Am J Cardiol. 2017 Mar 29. pii: S0002-9149(17)30339.
    PubMed     Text format     Abstract available


  16. BANKS A, Broderick S, Chiswell K, Shaw L, et al
    Comparison of Clinical Characteristics and Outcomes of Patients With Versus Without Diabetes Mellitus and With Versus Without Angina Pectoris (from the Duke Databank for Cardiovascular Disease).
    Am J Cardiol. 2017 Mar 16. pii: S0002-9149(17)30295.
    PubMed     Text format     Abstract available


  17. NEZARAT N, Budoff MJ, Luo Y, Darabian S, et al
    Presence, Characteristics, and Volumes of Coronary Plaque Determined by Computed Tomography Angiography in Young Type 2 Diabetes Mellitus.
    Am J Cardiol. 2017 Mar 1. pii: S0002-9149(17)30209.
    PubMed     Text format     Abstract available


    February 2017
  18. KOSMIDOU I, Redfors B, Dordi R, Dizon JM, et al
    Incidence, Predictors, and Outcomes of High-Grade Atrioventricular Block in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (from the HORIZONS-AMI Trial).
    Am J Cardiol. 2017 Feb 16. pii: S0002-9149(17)30118.
    PubMed     Text format     Abstract available


  19. ANDO T, Akintoye E, Telila T, Briasoulis A, et al
    Trends in Vascular Complications in High-Risk Patients Following Transcatheter Aortic Valve Replacement in the United States.
    Am J Cardiol. 2017 Feb 10. pii: S0002-9149(17)30127.
    PubMed     Text format     Abstract available


    January 2017
  20. ANDO T, Akintoye E, Telila T, Briasoulis A, et al
    Comparison of Hospital Outcome of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Diabetes Mellitus (from the Nationwide Inpatient Sample).
    Am J Cardiol. 2017 Jan 25. pii: S0002-9149(17)30048.
    PubMed     Text format     Abstract available


  21. ZAFRIR B, Jaffe R, Rubinshtein R, Karkabi B, et al
    Impact of Diabetes Mellitus on Long-Term Mortality in Patients Presenting for Coronary Angiography.
    Am J Cardiol. 2017 Jan 25. pii: S0002-9149(17)30049.
    PubMed     Text format     Abstract available


  22. FARHAN S, Baber U, Vogel B, Aquino M, et al
    Impact of Diabetes Mellitus on Ischemic Events in Men and Women After Percutaneous Coronary Intervention.
    Am J Cardiol. 2017 Jan 25. pii: S0002-9149(17)30063.
    PubMed     Text format     Abstract available


  23. CHEN DC, Singh GD, Armstrong EJ, Waldo SW, et al
    Long-Term Comparative Outcomes of Patients With Peripheral Artery Disease With and Without Concomitant Coronary Artery Disease.
    Am J Cardiol. 2017 Jan 25. pii: S0002-9149(17)30044.
    PubMed     Text format     Abstract available


    December 2016
  24. ARORA S, Patel P, Lahewala S, Patel N, et al
    Etiologies, Trends, and Predictors of 30-Day Readmission in Patients With Heart Failure.
    Am J Cardiol. 2016 Dec 14. pii: S0002-9149(16)31891.
    PubMed     Text format     Abstract available


  25. PEACOCK WF, Tamayo S, Sicignano N, Hopf KP, et al
    Comparison of the Incidence of Major Bleeding With Rivaroxaban Use Among Nonvalvular Atrial Fibrillation Patients With Versus Without Diabetes Mellitus.
    Am J Cardiol. 2016 Dec 9. pii: S0002-9149(16)31892.
    PubMed     Text format     Abstract available


  26. GOBARDHAN SN, Dimitriu-Leen AC, van Rosendael AR, van Zwet EW, et al
    Prevalence by Computed Tomographic Angiography of Coronary Plaques in South Asian and White Patients With Type 2 Diabetes Mellitus at Low and High Risk Using Four Cardiovascular Risk Scores (UKPDS, FRS, ASCVD, and JBS3).
    Am J Cardiol. 2016 Dec 2. pii: S0002-9149(16)31898.
    PubMed     Text format     Abstract available


    November 2016
  27. SUN Y, Liu X, He Y, Tang M, et al
    Meta-Analysis of Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Implantation.
    Am J Cardiol. 2016 Nov 16. pii: S0002-9149(16)31824.
    PubMed     Text format     Abstract available


  28. NICHOLS GA, Reynolds K, Olufade T, Kimes TM, et al
    Effect of Combination Cholesterol-Lowering Therapy and Triglyceride-Lowering Therapy on Medical Costs in Patients With Type 2 Diabetes Mellitus.
    Am J Cardiol. 2016 Nov 4. pii: S0002-9149(16)31740.
    PubMed     Text format     Abstract available


    September 2016
  29. GURBEL PA, Bliden KP, Chaudhary R, Patrick J, et al
    Antiplatelet Effect Durability of a Novel, 24-Hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus.
    Am J Cardiol. 2016 Sep 20. pii: S0002-9149(16)31504.
    PubMed     Text format     Abstract available


  30. KONISHI H, Miyauchi K, Shitara J, Endo H, et al
    Impact of Lipoprotein(a) on Long-term Outcomes in Patients With Diabetes Mellitus Who Underwent Percutaneous Coronary Intervention.
    Am J Cardiol. 2016 Sep 13. pii: S0002-9149(16)31474.
    PubMed     Text format     Abstract available


    August 2016
  31. TANG H, Fang Z, Wang T, Cui W, et al
    Meta-Analysis of Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cardiovascular Outcomes and All-Cause Mortality Among Patients With Type 2 Diabetes Mellitus.
    Am J Cardiol. 2016 Aug 31. pii: S0002-9149(16)31453.
    PubMed     Text format     Abstract available


  32. SUN JT, Liu Y, Lu L, Liu HJ, et al
    Diabetes-Invoked High-Density Lipoprotein and Its Association With Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus.
    Am J Cardiol. 2016 Aug 30. pii: S0002-9149(16)31435.
    PubMed     Text format     Abstract available


  33. DOMANSKI M, Farkouh ME, Zak V, French J, et al
    Relation of Post-Coronary Artery Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular Death in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease.
    Am J Cardiol. 2016 Aug 30. pii: S0002-9149(16)31432.
    PubMed     Text format     Abstract available


  34. VAN DIJK P, Mouden M, Hermanides RS
    Characterization of the Diabetes Population is Essential.
    Am J Cardiol. 2016 Aug 17. pii: S0002-9149(16)31348.
    PubMed     Text format    


  35. KENNEDY MW, Hermanides RS, Kaplan E, Hemradj V, et al
    Fractional Flow Reserve-Guided Deferred Versus Complete Revascularization in Patients With Diabetes Mellitus.
    Am J Cardiol. 2016 Aug 13. pii: S0002-9149(16)31329.
    PubMed     Text format     Abstract available


  36. KOHLI P, Knowles JW, Sarraju A, Waters DD, et al
    Metabolic Markers to Predict Incident Diabetes Mellitus in Statin-Treated Patients (from the Treating to New Targets and the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trials).
    Am J Cardiol. 2016 Aug 12. pii: S0002-9149(16)31324.
    PubMed     Text format     Abstract available


    July 2016
  37. KURIHARA O, Takano M, Mizuno K, Shibata Y, et al
    Impact of Diabetic Retinopathy on Vulnerability of Atherosclerotic Coronary Plaque and Incidence of Acute Coronary Syndrome.
    Am J Cardiol. 2016 Jul 18. pii: S0002-9149(16)31192.
    PubMed     Text format     Abstract available


    May 2016
  38. ARSENAULT BJ, Kohli P, Lambert G, DeMicco DA, et al
    Emerging Cardiovascular Disease Biomarkers and Incident Diabetes Mellitus Risk in Statin-Treated Patients With Coronary Artery Disease (from the Treating to New Targets [TNT] Study).
    Am J Cardiol. 2016 May 29. pii: S0002-9149(16)30947.
    PubMed     Text format     Abstract available


  39. PICCOLO R, Franzone A, Koskinas KC, Raber L, et al
    Effect of Diabetes Mellitus on Frequency of Adverse Events in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention.
    Am J Cardiol. 2016 May 14. pii: S0002-9149(16)30859.
    PubMed     Text format     Abstract available


    April 2016
  40. GIUSTINO G, Mehran R, Bansilal S, Feit F, et al
    Safety and Efficacy of Bivalirudin in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: From the REPLACE-2, ACUITY and HORIZONS-AMI Trials.
    Am J Cardiol. 2016 Apr 20. pii: S0002-9149(16)30485.
    PubMed     Text format     Abstract available


  41. TEHRANI DM, Zhao Y, Blaha MJ, Mora S, et al
    Discordance of Low-Density Lipoprotein and High-Density Lipoprotein Cholesterol Particle Versus Cholesterol Concentration for the Prediction of Cardiovascular Disease in Patients With Metabolic Syndrome and Diabetes Mellitus (from the Multi-Ethnic Stu
    Am J Cardiol. 2016 Apr 6. pii: S0002-9149(16)30427.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: